(S)-nicotine decreases expression ISO RGD:10298 6480464 Nicotine results in decreased expression of CCK mRNA CTD PMID:21955143 1,2-dimethylhydrazine multiple interactions ISO RGD:10298 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CCK mRNA CTD PMID:22206623 15-acetyldeoxynivalenol increases expression ISO RGD:10298 6480464 15-acetyldeoxynivalenol results in increased expression of CCK protein CTD PMID:24385417 17beta-estradiol affects expression ISO RGD:737505 6480464 Estradiol affects the expression of CCK mRNA CTD PMID:25321415 17beta-estradiol increases expression ISO RGD:10298 6480464 Estradiol results in increased expression of CCK mRNA CTD PMID:19693291 17beta-estradiol multiple interactions ISO RGD:10298 6480464 [Estradiol co-treated with Progesterone] results in increased expression of CCK mRNA CTD PMID:19693291 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [3 more ... CTD PMID:10919282 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:10298 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:10298 6480464 [2 more ... CTD PMID:25510870 2,3,4,7,8-Pentachlorodibenzofuran multiple interactions EXP 6480464 [3 more ... CTD PMID:10919282 2,3,4,7,8-Pentachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:10919282 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [3 more ... CTD PMID:10919282 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CCK mRNA, Tetrachlorodibenzodioxin results in decreased expression of CCK protein alternative form CTD PMID:10919282 more ... 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2-acetamidofluorene decreases expression EXP 6480464 2-Acetylaminofluorene results in decreased expression of CCK mRNA CTD PMID:22584684 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:10919282 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP 6480464 [3 more ... CTD PMID:10919282 3-acetyldeoxynivalenol increases expression ISO RGD:10298 6480464 3-acetyldeoxynivalenol results in increased expression of CCK protein CTD PMID:24385417 3H-1,2-dithiole-3-thione increases expression EXP 6480464 1, 2-dithiol-3-thione results in increased expression of CCK mRNA CTD PMID:19162173 5-aza-2'-deoxycytidine increases expression ISO RGD:737505 6480464 Decitabine results in increased expression of CCK mRNA CTD PMID:19151715 aflatoxin B1 increases expression ISO RGD:737505 6480464 Aflatoxin B1 results in increased expression of CCK mRNA CTD PMID:22100608 more ... ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CCK mRNA CTD PMID:16483693 apomorphine multiple interactions EXP 6480464 Naloxone inhibits the reaction [CCK protein results in decreased activity of Apomorphine] CTD PMID:3561887 apomorphine decreases activity EXP 6480464 CCK protein results in decreased activity of Apomorphine CTD PMID:3561887 arsenite(3-) increases methylation ISO RGD:737505 6480464 arsenite results in increased methylation of CCK promoter CTD PMID:23974009 benzo[a]pyrene increases expression ISO RGD:10298 6480464 Benzoapyrene results in increased expression of CCK mRNA CTD PMID:23735875 benzo[a]pyrene increases expression ISO RGD:737505 6480464 Benzoapyrene results in increased expression of CCK mRNA CTD PMID:32234424 benzo[a]pyrene increases methylation ISO RGD:737505 6480464 Benzoapyrene results in increased methylation of CCK exon CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:737505 6480464 Benzoapyrene affects the methylation of CCK 5' UTR, Benzoapyrene affects the methylation of CCK promoter CTD PMID:27901495 bis(2-chloroethyl) sulfide increases expression ISO RGD:737505 6480464 Mustard Gas results in increased expression of CCK mRNA CTD PMID:25102026 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CCK mRNA CTD PMID:25181051 , PMID:30816183 bisphenol A decreases methylation ISO RGD:10298 6480464 bisphenol A results in decreased methylation of CCK promoter CTD PMID:27312807 bromosulfophthalein multiple interactions ISO RGD:737505 6480464 Sulfobromophthalein inhibits the reaction [SLCO1B3 protein results in increased uptake of CCK protein modified form] CTD PMID:25106415 butanal increases expression ISO RGD:737505 6480464 butyraldehyde results in increased expression of CCK mRNA CTD PMID:26079696 butyric acid increases expression ISO RGD:10298 6480464 Butyric Acid results in increased expression of CCK mRNA CTD PMID:12431849 capsaicin multiple interactions ISO RGD:10298 6480464 [Capsaicin co-treated with CCK protein alternative form] results in increased expression of TAC1 protein more ... CTD PMID:10683199 capsaicin multiple interactions EXP 6480464 Capsaicin inhibits the reaction [CCK protein results in increased phosphorylation of MAPK1 protein], Capsaicin inhibits the reaction [CCK protein results in increased phosphorylation of MAPK3 protein] CTD PMID:22508518 carbon nanotube increases expression ISO RGD:10298 6480464 Nanotubes more ... CTD PMID:25554681 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of CCK mRNA CTD PMID:20682304 chlorpyrifos increases expression ISO RGD:10298 6480464 Chlorpyrifos results in increased expression of CCK mRNA CTD PMID:20350560 clozapine multiple interactions EXP 6480464 Clozapine inhibits the reaction [Dizocilpine Maleate results in decreased expression of CCK mRNA], Clozapine inhibits the reaction [Dizocilpine Maleate results in decreased expression of CCK protein] CTD PMID:16567023 clozapine increases expression EXP 6480464 Clozapine results in increased expression of CCK mRNA CTD PMID:10974607 copper atom multiple interactions ISO RGD:737505 6480464 [Disulfiram binds to Copper] which results in decreased expression of CCK mRNA CTD PMID:24690739 copper(0) multiple interactions ISO RGD:737505 6480464 [Disulfiram binds to Copper] which results in decreased expression of CCK mRNA CTD PMID:24690739 copper(II) sulfate increases expression ISO RGD:737505 6480464 Copper Sulfate results in increased expression of CCK mRNA CTD PMID:19549813 cylindrospermopsin increases expression ISO RGD:737505 6480464 cylindrospermopsin results in increased expression of CCK mRNA CTD PMID:24921660 deoxynivalenol increases expression ISO RGD:10298 6480464 deoxynivalenol results in increased expression of CCK protein CTD PMID:22903826 more ... deoxynivalenol increases secretion ISO RGD:10298 6480464 deoxynivalenol results in increased secretion of CCK protein CTD PMID:25787141 deoxynivalenol multiple interactions ISO RGD:10298 6480464 1-6-3-methoxyestra-1 more ... CTD PMID:25787141 , PMID:26979077 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of CCK mRNA CTD PMID:24893172 dinophysistoxin 1 increases expression ISO RGD:737505 6480464 dinophysistoxin 1 results in increased expression of CCK mRNA CTD PMID:28939011 disulfiram decreases expression EXP 6480464 Disulfiram results in decreased expression of CCK protein alternative form CTD PMID:8246921 disulfiram multiple interactions ISO RGD:737505 6480464 [Disulfiram binds to Copper] which results in decreased expression of CCK mRNA CTD PMID:24690739 dorsomorphin multiple interactions ISO RGD:737505 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 ethanol increases expression ISO RGD:10298 6480464 Ethanol results in increased expression of CCK mRNA CTD PMID:21955143 ethylene glycol bis(2-aminoethyl)tetraacetic acid multiple interactions ISO RGD:10298 6480464 Egtazic Acid inhibits the reaction [deoxynivalenol results in increased secretion of CCK protein] CTD PMID:25787141 fenamidone decreases expression ISO RGD:10298 6480464 fenamidone results in decreased expression of CCK mRNA CTD PMID:27029645 fluoxetine decreases expression ISO RGD:10298 6480464 Fluoxetine results in decreased expression of CCK mRNA CTD PMID:17105902 fluoxetine decreases expression EXP 6480464 Fluoxetine results in decreased expression of CCK mRNA CTD PMID:17033635 folic acid multiple interactions ISO RGD:10298 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CCK mRNA CTD PMID:22206623 Fusarenone X increases expression ISO RGD:10298 6480464 fusarenon-X results in increased expression of CCK protein CTD PMID:24385417 genistein increases expression ISO RGD:10298 6480464 Genistein results in increased expression of CCK mRNA CTD PMID:32186404 haloperidol increases expression EXP 6480464 Haloperidol results in increased expression of CCK mRNA CTD PMID:10974607 hydrogen peroxide affects expression ISO RGD:737505 6480464 Hydrogen Peroxide affects the expression of CCK mRNA CTD PMID:20044591 irinotecan affects expression EXP 6480464 Irinotecan affects the expression of CCK mRNA CTD PMID:20097248 kainic acid decreases expression EXP 6480464 Kainic Acid results in decreased expression of CCK protein CTD PMID:7774662 malathion increases expression EXP 6480464 Malathion results in increased expression of CCK mRNA CTD PMID:19784758 melatonin increases secretion EXP 6480464 Melatonin results in increased secretion of CCK protein CTD PMID:15009505 methamphetamine multiple interactions EXP 6480464 CCK protein modified form inhibits the reaction [Methamphetamine promotes the reaction [NCF1 protein binds to CYBB protein]], CCK protein modified form inhibits the reaction [Methamphetamine results in increased phosphorylation of NCF1 protein] CTD PMID:27565679 methotrexate increases expression ISO RGD:737505 6480464 Methotrexate results in increased expression of CCK mRNA CTD PMID:21678067 methylseleninic acid increases expression ISO RGD:737505 6480464 methylselenic acid results in increased expression of CCK mRNA CTD PMID:18548127 morphine decreases expression ISO RGD:10298 6480464 Morphine results in decreased expression of CCK mRNA CTD PMID:21955143 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of CCK mRNA CTD PMID:28801915 N-Nitrosopyrrolidine increases expression ISO RGD:737505 6480464 N-Nitrosopyrrolidine results in increased expression of CCK mRNA CTD PMID:32234424 naloxone multiple interactions EXP 6480464 Naloxone inhibits the reaction [CCK protein results in decreased activity of Apomorphine] CTD PMID:3561887 nicotine decreases expression ISO RGD:10298 6480464 Nicotine results in decreased expression of CCK mRNA CTD PMID:21955143 nitrendipine multiple interactions ISO RGD:10298 6480464 Nitrendipine inhibits the reaction [deoxynivalenol results in increased secretion of CCK protein] CTD PMID:25787141 nitrobenzenes increases expression EXP 6480464 Nitrobenzenes analog results in increased expression of CCK mRNA CTD PMID:19784758 Nivalenol increases expression ISO RGD:10298 6480464 nivalenol results in increased expression of CCK protein CTD PMID:24385417 octreotide decreases secretion ISO RGD:737505 6480464 Octreotide results in decreased secretion of CCK protein CTD PMID:11148435 more ... octreotide decreases response to substance ISO RGD:737505 6480464 Octreotide results in decreased susceptibility to CCK protein CTD PMID:2883060 orlistat multiple interactions ISO RGD:737505 6480464 [[orlistat results in decreased abundance of Fatty Acids more ... CTD PMID:11408251 , PMID:18303078 orlistat decreases secretion ISO RGD:737505 6480464 orlistat results in decreased secretion of CCK protein CTD PMID:18647814 paracetamol decreases expression ISO RGD:737505 6480464 Acetaminophen results in decreased expression of CCK mRNA CTD PMID:22230336 parathion increases expression EXP 6480464 Parathion results in increased expression of CCK mRNA CTD PMID:19784758 parathion-methyl affects expression EXP 6480464 Methyl Parathion affects the expression of CCK mRNA CTD PMID:19784758 parathion-methyl increases expression EXP 6480464 Methyl Parathion results in increased expression of CCK mRNA CTD PMID:19784758 parathion-methyl decreases expression EXP 6480464 Methyl Parathion results in decreased expression of CCK mRNA CTD PMID:19784758 PCB138 multiple interactions ISO RGD:10298 6480464 [2 more ... CTD PMID:25510870 pentanal increases expression ISO RGD:737505 6480464 pentanal results in increased expression of CCK mRNA CTD PMID:26079696 progesterone multiple interactions ISO RGD:10298 6480464 [Estradiol co-treated with Progesterone] results in increased expression of CCK mRNA CTD PMID:19693291 progesterone decreases expression ISO RGD:10298 6480464 Progesterone results in decreased expression of CCK mRNA CTD PMID:22238285 propanal increases expression ISO RGD:737505 6480464 propionaldehyde results in increased expression of CCK mRNA CTD PMID:26079696 resveratrol multiple interactions EXP 6480464 resveratrol inhibits the reaction [CCK protein results in decreased activity of CAT protein] CTD PMID:16499907 rotenone decreases expression ISO RGD:737505 6480464 Rotenone results in decreased expression of CCK mRNA CTD PMID:29955902 ruthenium red multiple interactions ISO RGD:10298 6480464 [N-2-hydroxy-3-2-cyano-3-chlorophenoxypropyl-1 more ... CTD PMID:26979077 SB 431542 multiple interactions ISO RGD:737505 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO RGD:737505 6480464 Silicon Dioxide analog results in increased expression of CCK mRNA CTD PMID:25895662 sodium fluoride decreases expression EXP 6480464 Sodium Fluoride results in decreased expression of CCK mRNA CTD PMID:27257137 Sodium oleate increases secretion ISO RGD:737505 6480464 osteum results in increased secretion of CCK protein CTD PMID:17138722 , PMID:18303078 testosterone increases expression ISO RGD:10298 6480464 Testosterone results in increased expression of CCK mRNA CTD PMID:19693291 testosterone decreases expression ISO RGD:10298 6480464 Testosterone results in decreased expression of CCK mRNA CTD PMID:19693291 tetrachloromethane increases expression ISO RGD:10298 6480464 Carbon Tetrachloride results in increased expression of CCK mRNA CTD PMID:17484886 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of CCK mRNA CTD PMID:23411599 titanium dioxide increases expression ISO RGD:10298 6480464 titanium dioxide results in increased expression of CCK mRNA CTD PMID:27760801 trichostatin A decreases expression ISO RGD:737505 6480464 trichostatin A results in decreased expression of CCK mRNA CTD PMID:24935251 triphenylphosphane oxide multiple interactions ISO RGD:10298 6480464 triphenylphosphine oxide inhibits the reaction [deoxynivalenol results in increased secretion of CCK protein] CTD PMID:25787141 U-73122 multiple interactions ISO RGD:10298 6480464 1-6-3-methoxyestra-1 more ... CTD PMID:25787141 valproic acid increases expression ISO RGD:737505 6480464 Valproic Acid results in increased expression of CCK mRNA CTD PMID:29154799 valproic acid multiple interactions ISO RGD:737505 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of CCK mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:737505 6480464 Valproic Acid results in decreased expression of CCK mRNA CTD PMID:26272509 valproic acid increases methylation ISO RGD:737505 6480464 Valproic Acid results in increased methylation of CCK gene CTD PMID:29154799 valproic acid affects expression ISO RGD:737505 6480464 Valproic Acid affects the expression of CCK mRNA CTD PMID:25979313 vorinostat multiple interactions ISO RGD:737505 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of CCK mRNA CTD PMID:27188386